Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma.

Mirabello L, Yu K, Berndt SI, Burdett L, Wang Z, Chowdhury S, Teshome K, Uzoka A, Hutchinson A, Grotmol T, Douglass C, Hayes RB, Hoover RN, Savage SA; National Osteosarcoma Etiology Study Group.

BMC Cancer. 2011 May 29;11:209. doi: 10.1186/1471-2407-11-209.

2.

Telomere length and variation in telomere biology genes in individuals with osteosarcoma.

Mirabello L, Richards EG, Duong LM, Yu K, Wang Z, Cawthon R, Berndt SI, Burdett L, Chowdhury S, Teshome K, Douglass C, Savage SA; National Osteosarcoma Etiology Study Group.

Int J Mol Epidemiol Genet. 2011 Jan 1;2(1):19-29. Epub 2010 Nov 23.

3.

Genetic variation at chromosome 8q24 in osteosarcoma cases and controls.

Mirabello L, Berndt SI, Seratti GF, Burdett L, Yeager M, Chowdhury S, Teshome K, Uzoka A, Douglass C, Hayes RB, Hoover RN, Savage SA; National Osteosarcoma Etiology Study Group.

Carcinogenesis. 2010 Aug;31(8):1400-4. doi: 10.1093/carcin/bgq117. Epub 2010 Jun 7.

4.

Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma.

Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ; National Osteosarcoma Etiology Study Group.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1667-74.

5.

Germ-line genetic variation of TP53 in osteosarcoma.

Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ; National Osteosarcoma Etiology study group.

Pediatr Blood Cancer. 2007 Jul;49(1):28-33.

PMID:
17096406

Supplemental Content

Loading ...
Support Center